United States · FDA National Drug Code directory

Lansoprazole

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
71335-1820_e66cf5f3-d909-40ad-a03d-c0423f41aa23
Product NDC
71335-1820
Form
CAPSULE, DELAYED RELEASE
Composition / generic term
Lansoprazole
Labeler
Bryant Ranch Prepack
Marketing category
ANDA
Marketing start / end (source format)
20180824
Source listing expiry
20261231

Source-listed ingredients

  • LANSOPRAZOLE — 30 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (71335-1820-1) · 71335-1820-1
  • 90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (71335-1820-2) · 71335-1820-2
  • 18 CAPSULE, DELAYED RELEASE in 1 BOTTLE (71335-1820-3) · 71335-1820-3
  • 28 CAPSULE, DELAYED RELEASE in 1 BOTTLE (71335-1820-4) · 71335-1820-4
  • 56 CAPSULE, DELAYED RELEASE in 1 BOTTLE (71335-1820-5) · 71335-1820-5
  • 58 CAPSULE, DELAYED RELEASE in 1 BOTTLE (71335-1820-6) · 71335-1820-6
  • 60 CAPSULE, DELAYED RELEASE in 1 BOTTLE (71335-1820-7) · 71335-1820-7
  • 180 CAPSULE, DELAYED RELEASE in 1 BOTTLE (71335-1820-8) · 71335-1820-8
  • 120 CAPSULE, DELAYED RELEASE in 1 BOTTLE (71335-1820-9) · 71335-1820-9

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →
Lansoprazole — United States | Molindra Medicines